BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33953794)

  • 1. TAP Test Image Dynamic Tracking Study after Thyroid Cancer Surgery and after Radiotherapy and Chemotherapy.
    Wang C; Gu Y; Men X; Sun P; Chen M
    Comput Math Methods Med; 2021; 2021():8072126. PubMed ID: 33953794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
    Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
    BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image Risk Assessment of the Thyroid Cancer Model Based on Discriminant Analysis and the Value of TAP and CEA Combined Detection.
    Wang B; Wang S; Lang S; Liang L; Yang Y; Xue Y; Xu Y
    J Healthc Eng; 2021; 2021():8836288. PubMed ID: 34422249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
    Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
    Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
    Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer.
    Tanaka K; Yano M; Motoori M; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Yamamoto T; Yamasaki T; Doki Y; Ishikawa O
    Ann Surg Oncol; 2010 Oct; 17(10):2779-86. PubMed ID: 20411433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer.
    Diez M; Gomez A; Hernando F; Ortega MD; Maestro ML; Torres A; Mugüerza JM; Gutierrez A; Granell J; Balibrea JL
    Int J Biol Markers; 1995; 10(1):5-10. PubMed ID: 7629428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K; Watanabe S
    Dis Esophagus; 1998 Jan; 11(1):35-9. PubMed ID: 9595230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study on multiple tumor markers following therapy in patients with uterine cervical carcinoma].
    Hiura M; Yorishima M; Tanaka M; Yokoyama T; Myoga H; Chiba T; Nakanishi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):471-8. PubMed ID: 2373919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer.
    Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang J; Luo Q; Su Y; Zhang S
    Med Oncol; 2014 May; 31(5):933. PubMed ID: 24737009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the treatment outcome in endometrial cancer patients by CEA and TATI.
    Kozakiewicz B; Chądzyńska M; Dmoch-Gajzlerska E; Stefaniak M
    Tumour Biol; 2016 Jul; 37(7):9367-74. PubMed ID: 26779635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
    Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
    Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer.
    Lara PC; Cuyás JM
    Cancer; 1995 Sep; 76(5):758-64. PubMed ID: 8625177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.